A magnifying glass examines frosted glass business research cards beside a folder and an abstract stock chart.
Blog

Best Halal Stocks to Watch: A Source-Dated Research List

A source-dated watchlist of five stock research candidates, with company filings, business risks, screening questions and a practical refresh checklist.
October 2, 2026
1-Min Summary

Written by Tarif Homsi, Founder & CEO

Short answer: There is no universal “best halal stock.” A useful watchlist starts with dated screening evidence and then evaluates business risk, price and portfolio fit. Eli Lilly, ExxonMobil, Linde, NVIDIA and Procter & Gamble are research examples below because they appeared in SPUS's official holdings dated October 2, 2026—not because this article independently approves or recommends them.

  • A fund holding is a research lead, not a permanent halal label or a buy signal.
  • Obtain a current stock-level screen under the methodology you follow before investing.
  • Review the company's filings, possible losses and overlap with investments you already own.

How this halal stock watchlist was selected

People searching for the best halal stocks usually want names they can investigate, not another unexplained list of familiar tickers. This guide offers five examples and a way to document the evidence behind each one. “To watch” means to research; it does not mean to buy, hold or sell.

The starting universe is the official holdings of the SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS). Its published portfolio dated October 2, 2026 included all five companies below. SP Funds describes the fund as following Shariah guidelines. Holdings can change, and a portfolio snapshot is not a stock-level screening report.

We selected these examples to illustrate different businesses, not to rank expected returns. They appear alphabetically by company name. The selection does not represent the entire screened-stock universe, a model portfolio or NoorVest's client holdings. We have not independently recalculated their current Shariah ratios for this article. Recheck the source and obtain a fresh individual-stock assessment before acting.

Five stock research candidates to watch

Illustrative candidates from SPUS holdings dated October 2, 2026. None is a buy recommendation.
Company / tickerBusiness to understandResearch questionAn important risk
Eli Lilly / LLYMedicinesHow dependent are results on particular treatments and manufacturing capacity?Clinical, regulatory and patent uncertainty
ExxonMobil / XOMEnergy and chemical productsHow would weaker commodity prices affect cash generation?Oil and gas price exposure
Linde / LINIndustrial gases and engineeringHow do customer demand and energy costs affect contracts and projects?Energy supply and cost uncertainty
NVIDIA / NVDAComputing and AI infrastructureHow much future growth does the share price already assume?Export restrictions and competition
Procter & Gamble / PGBranded consumer productsCan sales volumes and margins support the business at the price paid?Input costs and competitive pressure

The business descriptions and risks are grounded in the issuer reports linked below. The questions are our suggested research prompts. For every row, a current individual-stock Shariah assessment and a personal suitability review remain outstanding. Inclusion in this table does not resolve either question.

Eli Lilly (LLY): examine the medicine portfolio and its risks

Lilly's 2025 Form 10-K describes its medicines business and explains the uncertainty of drug development, dependence on intellectual property and challenges in expanding manufacturing capacity. Those issues matter even when a company has strong product demand.

A research note could distinguish existing treatments from unapproved candidates, identify which products drive results, and ask what happens if competition, pricing pressure or a failed trial changes the outlook. Do not treat a popular medicine or a promising pipeline as a guarantee of shareholder returns. Separately, obtain the latest screening report rather than inferring compliance from the healthcare category.

ExxonMobil (XOM): understand commodity exposure

ExxonMobil's 2025 annual filing covers its energy and chemical operations. Its 2025 results release illustrates how weaker crude realizations can affect earnings. A large business can still be sensitive to changes in prices and demand.

Ask whether your investment case depends on a favorable oil-price assumption, how spending commitments affect available cash, and whether this exposure adds to risks elsewhere in your portfolio. Environmental or other personal exclusions are an additional decision; a provider's financial screen does not automatically apply every investor's values preferences.

Linde (LIN): look beyond a familiar industrial name

Linde's 2025 annual report describes industrial gases and engineering operations. It identifies energy as a major production and distribution cost and notes uncertainty around energy availability and prices.

Read how supply agreements handle changing costs, which customers and regions drive demand, and what could delay major projects. A contract-based business deserves analysis of the contracts; it should not be assumed to provide bond-like certainty. Check the latest financial statements and screening method independently of this business description.

NVIDIA (NVDA): separate technology demand from stock value

NVIDIA's fiscal 2026 Form 10-K describes computing and AI infrastructure and discusses export-control, supply-chain and competitive risks. An exciting technology narrative does not tell you whether today's stock price is reasonable.

Write down the growth and profitability assumptions behind your valuation, then ask what would invalidate them. Check whether your funds, employer stock or other holdings already create technology concentration. Business growth and investment returns are different questions; buying a strong company at an unfavorable price can still lead to loss.

Procter & Gamble (PG): review volumes, costs and competition

P&G's fiscal 2026 Form 10-K describes branded consumer products across categories such as home care and personal care. It also discusses input-cost volatility, currency exposure and competition, including private-label products.

Investigate whether sales changes come from prices or from the quantity sold, how costs affect margins, and whether consumer preferences are changing. Everyday household demand does not make the shares risk-free. A dividend history, brand name or familiar product is not a substitute for a current screen or a valuation review.

What should “best” mean for your research?

Decide the selection criteria before looking at a list. Otherwise, a recent price rise can become the reason for buying, and the explanation is written afterward. A useful research candidate is one whose business you understand, whose compliance evidence is current and whose risks you can explain—not simply the company with the most enthusiastic online coverage.

Keep three decisions separate: whether the security is acceptable under your Shariah approach, whether the business and price make sense, and whether owning it fits your circumstances. A positive answer to the first does not establish the other two. None of the five names above is described as undervalued, safer than alternatives or likely to outperform.

  • Purpose: Are you researching long-term ownership, income or something else? Define the purpose without promising a result.
  • Evidence: Can you explain the revenue sources, financial position and principal risks using current filings?
  • Price: What assumptions must hold for the price to make sense, and how fragile are those assumptions?
  • Fit: Would a loss affect essential expenses, near-term plans or the concentration of your existing investments?

What to verify before calling a stock halal

Start with the exact listed security and a screening provider whose methodology you understand. Record the report date, financial-statement period, business exclusions, financial tests and any purification guidance. If two providers disagree, compare the underlying method and data rather than choosing whichever result permits the trade.

NoorVest's published AAOIFI-aligned process combines prohibited-business exclusions with three financial screens: interest-based debt below 30% of market capitalization, interest-earning deposits and securities below 30% of market capitalization, and prohibited income below 5% of total income. These are NoorVest's published thresholds, not evidence that this article has calculated a pass for any named company.

Read the halal stock investing guide for the full process and the AAOIFI standards reference for the standards context. Do not turn a company's industry label, a fund's holding or a historical screenshot into an undated compliance badge.

How to turn a ticker into a research file

The SEC's guide to reading a Form 10-K explains where to find the business description, risk factors, management discussion and financial statements. Use the latest quarterly filing as well as the annual report to check what has changed.

For each candidate, write a short case in your own words: how the company earns money, why customers choose it, what its obligations are, and what would make the case fail. Separate management's expectations from results already achieved. Make a note of unanswered questions rather than filling gaps with assumptions.

Then compare the current price with your assumptions about the business. This article supplies no target prices, analyst ratings, dividend-yield rankings or expected-return estimates. If your conclusion depends on unusually optimistic assumptions, acknowledge that uncertainty explicitly. A research file should make it easier to reject a weak idea as well as investigate an interesting one.

A five-stock list is not a diversified portfolio

The examples span different businesses, but that does not establish suitable weights or adequate diversification. The SEC's diversification guidance explains that spreading investments can reduce concentration risk, while still leaving investors exposed to market losses.

Look through your existing funds before adding individual shares. Owning a company directly and through an ETF increases the same underlying exposure; it does not automatically create a new source of diversification. Employer stock can add another layer of overlap. Compare actual holdings, not just the number of accounts or fund names.

For readers weighing individual companies against pooled investments, our halal ETF guide and index funds guide explain fund-level questions. Neither approach eliminates fees, taxes, screening changes or possible losses.

How to keep a halal stock watchlist current

Save a dated record rather than a permanent “halal” column. One practical format is: ticker and share type; screening provider and method; assessment date and data period; issuer filing reviewed; unresolved risks; and the next review trigger. Use “not yet verified” when an assessment is missing. An unknown is not a pass.

Revisit the file when new financial statements, a significant transaction, a business change or a provider-status update appears, and recheck before placing an order. Do not wait for a calendar reminder if material new information arrives. This page's October 2, 2026 snapshot remains a historical observation until the holdings and individual-stock evidence are actually reviewed again.

NoorVest's published process describes quarterly security reviews through MuslimXchange and annual purification reporting. Your own review needs to follow the method and professional guidance relevant to you. If a stock's assessment changes, keep the evidence and seek qualified advice on the appropriate response rather than treating a charitable payment as automatic permission to continue.

For income-focused questions, see our halal dividend stocks guide. Purification and Zakat are separate matters; our investment Zakat guide helps frame those discussions. Neither a screening label nor this watchlist removes ordinary tax or recordkeeping obligations.

Frequently asked questions

What are the best halal stocks to invest in?

There is no single best list for every investor. Begin with current Shariah evidence, then review the company's risks, valuation and portfolio fit. The five examples here are research candidates from a dated fund portfolio, not recommended investments.

Does this page confirm NVIDIA or Lilly is halal today?

No. It records their inclusion in SPUS holdings dated October 2, 2026. It does not independently calculate their current screening ratios. Obtain a fresh individual-stock report under the approach you follow before investing.

Is a stock automatically halal if a Shariah ETF owns it?

No automatic conclusion follows for every investor or future date. A fund holding provides a lead under that fund's process. Check its date and method, then obtain current security-level evidence and review how the trade will be carried out.

Why can two halal stock screeners disagree?

They may use different standards, financial definitions, data periods, denominators or update schedules. Compare the actual methods and obtain qualified guidance on unresolved differences instead of selecting a favorable label without understanding it.

Should I buy all five companies in the table?

The table is not a portfolio or allocation instruction. It does not establish that any name fits your goals, risk tolerance or existing holdings. Research can reasonably lead to deciding not to invest.

How often should I refresh my stock watchlist?

Recheck before a transaction and when relevant financial statements, business events or screening updates appear. Keep the date and source of each assessment. A scheduled review does not replace responding to material new information.

From a research list to a financial plan

The useful outcome of a watchlist is a documented decision process, not a longer collection of tickers. NoorVest's financial planning and investment management services can place investment questions alongside your goals and existing exposures. If that would help, request an introductory conversation.

Important disclosure

This article is educational and may be considered an advertisement for NoorVest. Named securities and the fund are illustrative research examples, not recommendations, religious rulings, a model portfolio or a statement of NoorVest client holdings. We have not independently verified a current Shariah pass or assessed suitability for any named stock in this article. The list does not rank performance, forecast returns or represent all available alternatives. Source holdings and screening assessments may change. Investing involves risk, including loss of principal. Consult qualified Shariah, investment and tax professionals about your circumstances.

About the author

Tarif Homsi is NoorVest's founder and CEO. His work focuses on financial planning and values-aligned wealth management for U.S. Muslim investors. Sources reviewed October 2, 2026.

Primary sources and further reading

Get Free Consultation
Light Mode
Toggle cloudsstars